{"id":"W4403535987","doi":"10.1093/rheumatology/keae580","title":"Deucravacitinib, a selective, TYK2 inhibitor, in psoriatic arthritis: achievement of minimal disease activity components in a phase 2 trial","year":2024,"lang":"en","type":"article","venue":"Lara D. Veeken","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"AbbVie; Celgene; Bristol-Myers Squibb Canada; Gilead Sciences; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Psoriatic arthritis; Arthritis; Internal medicine; Pharmacology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00333636,0.0008861847,0.00168285,0.0002969333,0.0003793262,0.0008144528,0.0005186776,0.001247109,0.002524736],"category_scores_gemma":[0.001816807,0.0003290928,0.001388539,0.0002719181,0.0004545145,0.000707404,0.0002628877,0.001915438,0.000343485],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006695553,"about_ca_system_score_gemma":0.001304771,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003969729,"about_ca_topic_score_gemma":0.001455064,"domain_scores_codex":[0.9988194,0.0006703322,0.00009696262,0.0001481064,0.0001325554,0.0001327034],"domain_scores_gemma":[0.9989629,0.0002846008,0.0002595026,0.00007288292,0.00009285639,0.0003273106],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.84174,0.02652808,0.004437574,0.001467453,0.001986408,0.0001806889,0.000209738,0.001249558,0.02516366,0.0002171239,0.002156205,0.09466355],"study_design_scores_gemma":[0.7090401,0.2742124,0.0087412,0.00007725935,0.0006954443,0.0003452273,0.00003307963,0.001200054,0.003677195,0.0001739098,0.001775583,0.00002844938],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9900968,0.004682649,0.000607479,0.0004609019,0.0001394343,0.00219621,0.0005467882,0.00005674758,0.001212967],"genre_scores_gemma":[0.9915867,0.002217135,0.001473921,0.0006198598,0.0002441538,0.001951494,0.0007902869,0.00001236794,0.001104112],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00333636,"threshold_uncertainty_score":0.01764452,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02694407506483947,"score_gpt":0.3059602927616386,"score_spread":0.2790162176967991,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}